-
1دورية أكاديمية
المساهمون: Ho Sup Lee, Kihyun Kim, Je-Jung Lee, Sung-Soo Yoon, Soo-Mee Bang, Jin Seok Kim, Hyeon-Seok Eom, Dok Hyun Yoon, Yoojin Lee, Ho-Jin Shin, Yong Park, Jae-Cheol Jo, Won Sik Lee, Young Rok Do, Yeung-Chul Mun, Mark Hong Lee, Hyo Jung Kim, Sung-Hyun Kim, Min Kyoung Kim, Sung-Nam Lim, Seong Kyu Park, Jun Ho Yi, Jae Hoon Lee, Chang-Ki Min, Kim, Jin Seok
مصطلحات موضوعية: Aged, 80 and over, Bortezomib / adverse effects, Dexamethasone / administration & dosage, Dexamethasone / adverse effects, Disease-Free Survival, Drug Therapy, Combination, Female, Frailty / etiology, Humans, Lenalidomide / administration & dosage, Lenalidomide / adverse effects, Male, Middle Aged, Multiple Myeloma / drug therapy, Multiple Myeloma / mortality, Recurrence, Treatment Failure, Treatment Outcome, Elderly multiple myeloma, Frailty, Lenalidomide and dexamethasone, Relapsed and refractory, Survival
العلاقة: INTERNATIONAL JOURNAL OF HEMATOLOGY; J01120; OAK-2022-05301; https://ir.ymlib.yonsei.ac.kr/handle/22282913/191083Test; https://link.springer.com/article/10.1007/s12185-020-02988-6Test; T9992022489; INTERNATIONAL JOURNAL OF HEMATOLOGY, Vol.113(1) : 81-91, 2021-01
الإتاحة: https://doi.org/10.1007/s12185-020-02988-6Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/191083Test -
2دورية أكاديمية
المساهمون: Jonathan L Kaufman, Meletios A Dimopoulos, Darrell White, Lotfi Benboubker, Gordon Cook, Merav Leiba, James Morton, P Joy Ho, Kihyun Kim, Naoki Takezako, Philippe Moreau, Heather J Sutherland, Hila Magen, Shinsuke Iida, Jin Seok Kim, H Miles Prince, Tara Cochrane, Albert Oriol, Nizar J Bahlis, Ajai Chari, Lisa O'Rourke, Sonali Trivedi, Tineke Casneuf, Maria Krevvata, Jon Ukropec, Rachel Kobos, Hervé Avet-Loiseau, Saad Z Usmani, Jesus San-Miguel, Kim, Jin Seok
مصطلحات موضوعية: Antibodies, Monoclonal / administration & dosage, Monoclonal / adverse effects, Antineoplastic Combined Chemotherapy Protocols / administration & dosage, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Chromosome Deletion, Chromosomes, Human, Cytogenetic Analysis, Dexamethasone / administration & dosage, Dexamethasone / adverse effects, Disease-Free Survival, Humans, Lenalidomide / administration & dosage, Lenalidomide / adverse effects, Multiple Myeloma* / drug therapy, Multiple Myeloma* / genetics, Multiple Myeloma* / mortality, Recurrence, Survival Rate, Translocation, Genetic
العلاقة: BLOOD CANCER JOURNAL; J00342; OAK-2021-02634; https://ir.ymlib.yonsei.ac.kr/handle/22282913/183932Test; T202007248; BLOOD CANCER JOURNAL, Vol.10(11) : 111, 2020-11
الإتاحة: https://doi.org/10.1038/s41408-020-00375-2Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/183932Test -
3دورية أكاديمية
المساهمون: Ho Sup Lee, Kihyun Kim, Seok Jin Kim, Je-Jung Lee, Inho Kim, Jin Seok Kim, Hyeon-Seok Eom, Dok Hyun Yoon, Cheolwon Suh, Ho-Jin Shin, Yeung-Chul Mun, Min Kyoung Kim, Sung-Nam Lim, Chul Won Choi, Hye Jin Kang, Sung-Soo Yoon, Chang-Ki Min, Kim, Jin Seok
مصطلحات موضوعية: Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Bortezomib / administration & dosage, Cyclophosphamide / administration & dosage, Cyclophosphamide / adverse effects, Dexamethasone / administration & dosage, Dexamethasone / adverse effects, Drug Resistance, Neoplasm, Febrile Neutropenia / epidemiology, Febrile Neutropenia / etiology, Female, Frail Elderly, Frailty / complications, Frailty / diagnosis, Hematologic Diseases / chemically induced, Hematologic Diseases / epidemiology, Humans, Incidence, Infections / epidemiology, Kaplan-Meier Estimate, Lenalidomide / administration & dosage, Male, Melphalan / administration & dosage, Middle Aged, Multiple Myeloma / drug therapy, Multiple Myeloma / genetics, Myeloma Proteins / analysis
العلاقة: AMERICAN JOURNAL OF HEMATOLOGY; J00085; OAK-2022-03777; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190136Test; T9992020361; AMERICAN JOURNAL OF HEMATOLOGY, Vol.95(4) : 413-421, 2020-04
الإتاحة: https://doi.org/10.1002/ajh.25726Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190136Test -
4دورية أكاديمية
المؤلفون: Spicka, Ivan, Ocio, Enrique María, Oakervee, Heather H.E., Greil, Richard, Banh, Raymond H, Huang, Shang Yi, D'Rozario, James M, Dimopoulos, Meletios Athanassios, Martínez, Sara, Extremera, Sonia, Kahatt, Carmen, Alfaro, Vicente, Carella, Angelo Michele, Meuleman, Nathalie, Hájek, Roman, Symeonidis, Argiris, Min, Chang Ki, Cannell, Paul, Ludwig, Heinz, Sonneveld, Pieter, Mateos, Maria-Victoria
المصدر: Annals of hematology, 98 (9
مصطلحات موضوعية: Sciences bio-médicales et agricoles, Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols -- administration & dosage, Bortezomib -- administration & dosage, Depsipeptides -- administration & dosage, Dexamethasone -- administration & dosage, Disease-Free Survival, Female, Humans, Lenalidomide -- administration & dosage, Male, Middle Aged, Multiple Myeloma -- drug therapy -- mortality, Survival Rate, Thalidomide -- administration & dosage, Dexamethasone, Multiple myeloma, Plitidepsin, Refractory, Relapsed
وصف الملف: 1 full-text file(s): application/pdf
العلاقة: uri/info:doi/10.1007/s00277-019-03739-2; uri/info:pii/10.1007/s00277-019-03739-2; uri/info:pmid/31240472; uri/info:pmcid/PMC6700046; https://dipot.ulb.ac.be/dspace/bitstream/2013/302974/1/doi_286618.pdfTest; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/302974Test
-
5دورية أكاديمية
المؤلفون: Facon, T., Kumar, Shaji, Plesner, T., Orlowski, R. Z., Moreau, P., Bahlis, N., Basu, S., Nahi, H., Hulin, C., Quach, H., Goldschmidt, H., O’Dwyer, M., Perrot, A., Venner, C. P., Weisel, K., Mace, J. R., Raje, N., Attal, M., Tiab, M., Macro, M., Frenzel, L., Leleu, X., Ahmadi, T., Chiu, C., Wang, J., Rampelbergh, R. Van, Uhlar, C. M., Kobos, R., Qi, M., Usmani, S. Z., Abildgaard, Niels
المصدر: Facon , T , Kumar , S , Plesner , T , Orlowski , R Z , Moreau , P , Bahlis , N , Basu , S , Nahi , H , Hulin , C , Quach , H , Goldschmidt , H , O’Dwyer , M , Perrot , A , Venner , C P , Weisel , K , Mace , J R , Raje , N , Attal , M , Tiab , M , Macro , M , Frenzel , L , Leleu , X , Ahmadi , T , Chiu , C , ....
مصطلحات موضوعية: Aged, 80 and over, Antibodies, Monoclonal/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Dexamethasone/administration & dosage, Female, Humans, Lenalidomide/administration & dosage, Male, Middle Aged, Multiple Myeloma/drug therapy, Neutropenia/chemically induced, Progression-Free Survival
وصف الملف: application/pdf
العلاقة: https://portal.findresearcher.sdu.dk/da/publications/c0aa869b-392f-4992-826b-d304d22e9023Test
الإتاحة: https://doi.org/10.1056/NEJMoa1817249Test
https://portal.findresearcher.sdu.dk/da/publications/c0aa869b-392f-4992-826b-d304d22e9023Test
https://findresearcher.sdu.dk/ws/files/157632593/nejmoa1817249.pdfTest -
6
المؤلفون: Pieter Sonneveld, Meletios A. Dimopoulos, Meral Beksac, Bronno van der Holt, Sara Aquino, Heinz Ludwig, Sonja Zweegman, Thilo Zander, Elena Zamagni, Ruth Wester, Roman Hajek, Lucia Pantani, Luca Dozza, Francesca Gay, AnneMaria Cafro, Luca De Rosa, Annamaria Morelli, Henrik Gregersen, Nina Gulbrandsen, Petra Cornelisse, Rosella Troia, Stefania Oliva, Vincent van de Velden, KaLung Wu, Paula F. Ypma, Gerard Bos, Mark-David Levin, Luca Pour, Christoph Driessen, Annemiek Broijl, Alexandra Croockewit, Monique C. Minnema, Anders Waage, Cecilie Hveding, Niels W. C. J. van de Donk, Massimo Offidani, Giuseppe A. Palumbo, Andrew Spencer, Mario Boccadoro, Michele Cavo
المساهمون: Interne Geneeskunde, MUMC+: MA Hematologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Hematology, Immunology, CCA - Cancer Treatment and quality of life, Sonneveld P., Dimopoulos M.A., Beksac M., van der Holt B., Aquino S., Ludwig H., Zweegman S., Zander T., Zamagni E., Wester R., Hajek R., Pantani L., Dozza L., Gay F., Cafro A., De Rosa L., Morelli A., Gregersen H., Gulbrandsen N., Cornelisse P., Troia R., Oliva S., van de Velden V., Wu K., Ypma P.F., Bos G., Levin M.-D., Pour L., Driessen C., Broijl A., Croockewit A., Minnema M.C., Waage A., Hveding C., van de Donk N.W.C.J., Offidani M., Palumbo G.A., Spencer A., Boccadoro M., Cavo M.
المصدر: Sonneveld, P, Dimopoulos, M A, Beksac, M, van der Holt, B, Aquino, S, Ludwig, H, Zweegman, S, Zander, T, Zamagni, E, Wester, R, Hajek, R, Pantani, L, Dozza, L, Gay, F, Cafro, A M, De Rosa, L, Morelli, A, Gregersen, H, Gulbrandsen, N, Cornelisse, P, Troia, R, Oliva, S, van de Velden, V, Wu, K L, Ypma, P F, Bos, G, Levin, M D, Pour, L, Driessen, C, Broijl, A, Croockewit, A, Minnema, M C, Waage, A, Hveding, C, van de Donk, N W C J, Offidani, M, Palumbo, G A, Spencer, A, Boccadoro, M & Cavo, M 2021, ' Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 39, no. 32, pp. 3613-3622 . https://doi.org/10.1200/JCO.21.01045Test
Journal of Clinical Oncology, 39, 32, pp. 3613-3622
Journal of Clinical Oncology, 39, 3613-3622
Journal of Clinical Oncology, 39(32), 3613-3622. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(32), 3613-3622. American Society of Clinical Oncology
Sonneveld, P, Dimopoulos, M A, Beksac, M, van der Holt, B, Aquino, S, Ludwig, H, Zweegman, S, Zander, T, Zamagni, E, Wester, R, Hajek, R, Pantani, L, Dozza, L, Gay, F, Cafro, A, De Rosa, L, Morelli, A, Gregersen, H, Gulbrandsen, N, Cornelisse, P, Troia, R, Oliva, S, van de Velden, V, Wu, K, Ypma, P F, Bos, G, Levin, M-D, Pour, L, Driessen, C, Broijl, A, Croockewit, A, Minnema, M C, Waage, A, Hveding, C, van de Donk, N W C J, Offidani, M, Palumbo, G A, Spencer, A, Boccadoro, M & Cavo, M 2021, ' Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma ', Journal of Clinical Oncology, vol. 39, no. 32, JCO2101045, pp. 3613-3622 . https://doi.org/10.1200/JCO.21.01045Testمصطلحات موضوعية: Oncology, Cancer Research, Neoplasm, Residual, Time Factors, THERAPY, Consolidation (business), Antineoplastic Combined Chemotherapy Protocols, IMPROVES, Lenalidomide/administration & dosage, Lenalidomide, Multiple myeloma, OUTCOMES, INDUCTION, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Middle Aged, OPEN-LABEL, Progression-Free Survival, DEXAMETHASONE, Europe, Residual, Multiple Myeloma, Human, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], Adult, Dexamethasone/administration & dosage, medicine.medical_specialty, Time Factor, Adolescent, Multiple Myeloma/drug therapy, BORTEZOMIB, Newly diagnosed, Maintenance Chemotherapy, Young Adult, SDG 3 - Good Health and Well-being, Internal medicine, medicine, Humans, Aged, Neoplasm Staging, Antineoplastic Combined Chemotherapy Protocol, business.industry, STEM-CELL TRANSPLANTATION, medicine.disease, Consolidation Chemotherapy, LENALIDOMIDE MAINTENANCE, Bortezomib/administration & dosage, Neoplasm, CONSENSUS, business
وصف الملف: STAMPA
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d062212186695d034b375b07fa82bfadTest
https://research.vumc.nl/en/publications/2b32098e-ca08-476c-9883-09664c6f97bcTest -
7
المؤلفون: Stephan Fuhrmann, Peter Brossart, Markus Munder, Mathias Hänel, Anja Seckinger, Katja Weisel, Hartmut Goldschmidt, Helga Bernhard, Jan Dürig, Anna Jauch, Martin Goerner, Christina Kunz, Hans-Walter Lindemann, Steffen Luntz, Ahmet H. Elmaagacli, Igor Wolfgang Blau, Hans Salwender, Maximilian Merz, Sandra Sauer, Marc S. Raab, Martin Hoffmann, Elias K. Mai, Kaya Miah, Axel Benner, Dirk Hose, Uta Bertsch, Christof Scheid
المساهمون: Hematology, Basic (bio-) Medical Sciences
المصدر: Leukemia
مصطلحات موضوعية: Adult, Male, Melphalan, Cancer Research, medicine.medical_specialty, Multiple Myeloma/drug therapy, Medizin, Myeloma, Induction Chemotherapy/mortality, Article, Bortezomib, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Lenalidomide/administration & dosage, Humans, Medicine, Prospective Studies, Adverse effect, Lenalidomide, Multiple myeloma, Aged, Aged, 80 and over, business.industry, Correction, High dose melphalan, Consolidation Chemotherapy/mortality, Induction Chemotherapy, Hematology, Middle Aged, Prognosis, medicine.disease, Stem-cell research, Consolidation Chemotherapy, Survival Rate, Transplantation, Oncology, Toxicity, Randomized controlled trials, Bortezomib/administration & dosage, Female, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Multiple Myeloma, business, Follow-Up Studies, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abdfae6314551f474fd5c284e7f37463Test
https://doi.org/10.1038/s41375-020-0976-9Test -
8
المؤلفون: Martin Goerner, Markus Munder, Martin Hoffmann, Katja Weisel, Peter Brossart, Elias K. Mai, Anja Seckinger, Hans Salwender, Bernhard Rabold, Dirk Hose, Thomas Hielscher, Igor Wolfgang Blau, Uta Bertsch, Steffen Luntz, Ahmet H. Elmaagacli, Stefanie Huhn, Nicola Giesen, Hartmut Goldschmidt, Jens Hillengass, Marc S. Raab, Christina Kunz, Christof Scheid, Anna Jauch, Maximilian Merz, Diana Tichy, Barbara Hügle-Dörr, Hans-Walter Lindemann, Mathias Hänel, Helga Bernhard, Jan Dürig, Stephan Fuhrmann
المساهمون: Hematology, Basic (bio-) Medical Sciences
المصدر: Leukemia. 34:1853-1865
مصطلحات موضوعية: Male, 0301 basic medicine, Melphalan, Oncology, Cancer Research, Medizin, Dexamethasone, Cyclophosphamide/administration & dosage, Bortezomib, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Lenalidomide/administration & dosage, Medicine, Hematopoietic Stem Cell Transplantation/mortality, Prospective Studies, Lenalidomide, Multiple myeloma, education.field_of_study, Maintenance Chemotherapy/mortality, Remission Induction, Hazard ratio, Hematopoietic Stem Cell Transplantation, Hematology, Prognosis, Combined Modality Therapy, Thalidomide, Survival Rate, 030220 oncology & carcinogenesis, Female, Multiple Myeloma, medicine.drug, Dexamethasone/administration & dosage, Melphalan/administration & dosage, medicine.medical_specialty, Population, Transplantation, Autologous, Maintenance Chemotherapy, 03 medical and health sciences, Internal medicine, Internal Medicine, Humans, education, Cyclophosphamide, Survival rate, Aged, Thalidomide/administration & dosage, business.industry, Consolidation Chemotherapy/mortality, medicine.disease, Multiple Myeloma/pathology, Consolidation Chemotherapy, Transplantation, 030104 developmental biology, Bortezomib/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, business, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37d3744d392b8b60be666bc6b8b4d70dTest
https://doi.org/10.1038/s41375-020-0724-1Test -
9
المؤلفون: Kaya Veelken, Axel Benner, Dirk Hose, Julia Krzykalla, Nicholas Schreck, Ute Hegenbart, Marco Basset, Anna Jauch, Anja Seckinger, Christoph Kimmich, Tobias Dittrich, Hartmut Goldschmidt, Stefan Schönland, Carsten Müller-Tidow
المساهمون: Hematology, Basic (bio-) Medical Sciences
المصدر: British journal of haematologyReferences. 195(2)
مصطلحات موضوعية: Melphalan, Dexamethasone/administration & dosage, Peptide Fragments/metabolism, Adult, Male, medicine.medical_specialty, Antineoplastic Agents, Hormonal, Renal function, Drug Therapy, Combination/methods, Immunoglobulin Light-chain Amyloidosis/diagnosis, Biomarkers/metabolism, Gastroenterology, Dexamethasone, Cohort Studies, Recurrence, Internal medicine, Natriuretic Peptide, Brain, medicine, AL amyloidosis, Natriuretic Peptide, Brain/metabolism, Lenalidomide/administration & dosage, Humans, Immunologic Factors, Immunoglobulin Light-chain Amyloidosis, Lenalidomide, Aged, Retrospective Studies, business.industry, hematology, Standard treatment, Hazard ratio, Middle Aged, Brain natriuretic peptide, medicine.disease, Prognosis, Peptide Fragments, Progression-Free Survival, Antineoplastic Agents, Hormonal/administration & dosage, Drug Therapy, Combination, Female, Immunoglobulin Light Chains, business, Immunoglobulin Light Chains/immunology, Immunologic Factors/administration & dosage, Biomarkers, medicine.drug, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f172245801c69fb813a7738b8000ca6eTest
https://pubmed.ncbi.nlm.nih.gov/34374083Test -
10دورية أكاديمية
المؤلفون: Sonneveld, Pieter, Dimopoulos, Meletios A, Beksac, Meral, van der Holt, Bronno, Aquino, Sara, Ludwig, Heinz, Zweegman, Sonja, Zander, Thilo, Zamagni, Elena, Wester, Ruth, Hajek, Roman, Pantani, Lucia, Dozza, Luca, Gay, Francesca, Cafro, AnneMaria, De Rosa, Luca, Morelli, Annamaria, Gregersen, Henrik, Gulbrandsen, Nina, Cornelisse, Petra, Troia, Rosella, Oliva, Stefania, van de Velden, Vincent, Wu, KaLung, Ypma, Paula F, Bos, Gerard, Levin, Mark-David, Pour, Luca, Driessen, Christoph, Broijl, Annemiek, Croockewit, Alexandra, Minnema, Monique C, Waage, Anders, Hveding, Cecilie, van de Donk, Niels W C J, Offidani, Massimo, Palumbo, Giuseppe A, Spencer, Andrew, Boccadoro, Mario, Cavo, Michele
المصدر: Sonneveld , P , Dimopoulos , M A , Beksac , M , van der Holt , B , Aquino , S , Ludwig , H , Zweegman , S , Zander , T , Zamagni , E , Wester , R , Hajek , R , Pantani , L , Dozza , L , Gay , F , Cafro , A , De Rosa , L , Morelli , A , Gregersen , H , Gulbrandsen , N , Cornelisse , P , Troia , R , Oliva , S , van de Velden , V , Wu ....
مصطلحات موضوعية: Adolescent, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Bortezomib/administration & dosage, Consolidation Chemotherapy, Dexamethasone/administration & dosage, Europe, Humans, Lenalidomide/administration & dosage, Maintenance Chemotherapy, Middle Aged, Multiple Myeloma/drug therapy, Neoplasm Staging, Neoplasm, Residual, Progression-Free Survival, Time Factors, Young Adult, DEXAMETHASONE, CONSENSUS, INDUCTION, THERAPY, IMPROVES, STEM-CELL TRANSPLANTATION, OPEN-LABEL, BORTEZOMIB, OUTCOMES, LENALIDOMIDE MAINTENANCE
الإتاحة: https://doi.org/10.1200/JCO.21.01045Test
https://cris.maastrichtuniversity.nl/en/publications/37b7a8fc-d238-427c-b058-68bd1196d880Test
النص الكامل